Sahlgrenska Science Park, Sahlgrenska Universitetssjukhus och CCRM Nordic har stärkt kunskapen om avancerade terapier i Västsverige. Projektet har bidragit till utbildningar, nätverk och samarbete mellan vård, forskning och näringsliv för att utveckla effektiva behandlingar.
Flera bolag inom Sahlgrenska Science Park har den senaste tiden nått avgörande milstolpar – från förvärv till kapitalanskaffning inför fas II/III-studier i Europa och USA. Sammantaget visar utvecklingen att bolagen tar klivet från tidig tillväxt till mer etablerade faser med internationell räckvidd.
The Life Science Barometer, initiated by SwedenBio, provides an important snapshot of the current state of the Swedish life science sector. Based on extensive data and industry input, the Barometer supports decision-making across industry, investment, and policy.
Life science-företaget Verigraft är årets mottagare av Arvid Carlsson Award 2025 för sin innovativa teknologi som möjliggör patientanpassade transplantat utan behov av immunosuppression.– Det här priset är ett betydelsefullt erkännande av vårt teams hårda arbete och av potentialen inom individanpassad regenerativ terapi, säger Petter Björquist, vd för Verigraft.
Sahlgrenska Science Park delar å
West Sweden’s thriving life sciences sector has been awarded a SEK 16.3 million grant from the European Regional Development Fund (via Tillväxtverket) and Region Västra Götaland (VGR) to enhance Advanced Therapy Medicinal Products (ATMP) competencies.
This strategic initiative brings together healthcare, academia and industry to foster collaboration and accelerate skill development, empowering
Sahlgrenska Science Park (SSP) and Oasia Ventures Pte. Ltd. are pleased to announce the signing of a Memorandum of Understanding (MOU) to accelerate Nordic health innovation in Singapore and South East Asia. The collaboration aims to support innovative health ventures in breaking new ground and creating global impact.
“This collaboration exemplifies our mission to accelerate health innovation b
========
Sahlgrenska Science Park shares news and information about its operations, portfolio companies and alumni companies.
=======
VERIGRAFT, a pioneer in personalized tissue therapies, has today publicly launched a crowdfunding campaign on Capital Cell to accelerate future treatments for vascular disease. This groundbreaking initiative seeks to raise funds to advance its innovative te
Idåg lanseras Sahlgrenska Global Health Hackathon (SGHH) på Park Annual i Göteborg. Det är startskottet för ett årslångt, globalt samarbete (co-action) med fokus på att ta itu med kritiska globala hälsoutmaningar.
Hackatonet SGHH samlar individer från tre kontinenter, sex länder och nio hotspots för innovation inom hälso- och sjukvården - studenter, forskare, yrkesverksamma, innovatörer och pas
Today marks the exciting launch of the Sahlgrenska Global Health Hackathon (SGHH) at Park Annual in Gothenburg, kicking off a year-long, global collaboration (co-action) focused on addressing critical global health challenges.
SGHH unites individuals from across three continents, six countries, and nine healthcare innovation hotspots-bringing together students, researchers, professionals, innov
INBJUDAN: Om bara en vecka startar Sahlgrenska Global Health Hackathon på Park Annual i Göteborg. Det blir startskottet för ett globalt samarbete (co-action) med sikte på att möta de globala hälsoutmaningarna.
Inspirerad av framgångarna med årets innovationshackathon inom femtech, HackHERHealth, kommer Sahlgrenska Global Health Hackathon (SGHH) att mobilisera människor från alla samhällsskikt –
MEDIA INVITATION: In just one week, the Sahlgrenska Global Health Hackathon will launch at the Park Annual event in Gothenburg, kicking off global collaborative action (co-action) aimed at addressing global health challenges.
Inspired by the success of the femtech innovation hackathon, HackHERHealth, the Sahlgrenska Global Health Hackathon (SGHH) will bring together people from all walks of lif
Biotech Fluidics, in collaboration with Sahlgrenska Science Park, has officially launched Ventri Labs AB (VentriLabs), a spinout company advancing patented technology for the gentle pumping of biological fluids.
Based at Sahlgrenska Science Park in Gothenburg, VentriLabs will be part of the CO-AX accelerator program, benefiting from access to health innovation labs, a vibrant entrepreneurial co
(Länk till svenskversion)
Sahlgrenska Science Park and Business Region Göteborg (BRG), in collaboration with Region Västra Götaland and Sahlgrenska University Hospital, have taken leading roles in the prestigious PRECISEU project. This European initiative aims to connect innovation ecosystems across Europe to efficiently advance towards truly personalized healthcare.
The PRECISEU project is
Sahlgrenska Science Park - in collaboration with Region Västra Götaland, the ATMP Center and Gothia Forum at Sahlgrenska University Hospital, and CCRM Nordic - proudly announces a European Social Fund grant for the “Competence development for ATMP” project. The project, with a total budget of SEK 10.4 million, includes co-financing from the Environmental and Regional Development Committee at Regio
Sahlgrenska Science Park is excited to announce the launch of its latest growth initiative through its CO-AX Accelerator program. CO-AX Accelerator Growth by Sahlgrenska Science Park is designed to accelerate the growth of small and medium-sized enterprises (SMEs) with tech solutions addressing global health challenges.
CO-AX Accelerator Growth will provide SMEs with support and a global networ
Sahlgrenska Science Park is excited to announce the appointment of Mats Hellström as Sahlgrenska Science Park's new Lab Manager. With this addition, Sahlgrenska Science Park extends its commitment to provide value-adding support for entrepreneurs, researchers and clinicians to accelerate their research in the newly opened Health Innovation Labs™ on Medicinareberget in Gothenburg.
A lab
The gender health gap is real. Women have higher rates of sick leave than men, are more affected by mental illness, and have been historically underrepresented in medical research.
This gender health gap must be reduced and completely eradicated. To address this societal problem and generate concrete solutions to solve it, Sahlgrenska Science Park, GoCo Health Innovation City, AstraZeneca, and
The HealthTech Award 2024 is now accepting entries! This prestigious award, a celebration of healthtech innovations that significantly impact people's lives, invites companies from the Nordics and Baltics to participate.
Organized by GREAT, Vitalis and Sahlgrenska Science Park’s CO-AX accelerator, this 4th edition recognizes pioneering companies that have developed healthtech solutions demonstr
Building on its legacy of fostering impactful healthtech innovations, the CO-AX accelerator at Sahlgrenska Science Park opens its doors for the spring 2024 batch of entrepreneurial talent. This call is directed towards innovators and startups who are leveraging technology to address global health challenges.
CO-AX, the healthtech accelerator at Sahlgrenska Science Park, proudly acknowledges the recent achievements of VERIGRAFT, a prominent member of its life science community. VERIGRAFT has reached a major regulatory safety milestone in the TECVI-1 trial, further supported by extended funding from Vinnova CAMP for their arterial graft development project.
TECVI-1 trial: a major step forward
The
